Clal Biotechnology Industries Ltd. (CBI.TA)
ILA 35.6
(-0.84%)
ILA 35.6
(-0.84%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 30.31 Million ILS | 304.81% |
| 2022 | 7.48 Million ILS | -19.03% |
| 2021 | 9.24 Million ILS | 61.84% |
| 2020 | 5.71 Million ILS | -18.45% |
| 2019 | 7 Million ILS | -85.88% |
| 2018 | 49.62 Million ILS | -30.96% |
| 2017 | 71.87 Million ILS | -8.21% |
| 2016 | 78.3 Million ILS | -8.09% |
| 2015 | 85.2 Million ILS | -1.72% |
| 2014 | 86.69 Million ILS | -26.59% |
| 2013 | 118.09 Million ILS | 363.68% |
| 2012 | 25.46 Million ILS | 124.15% |
| 2011 | 11.36 Million ILS | 20.3% |
| 2010 | 9.44 Million ILS | 115.49% |
| 2009 | 4.38 Million ILS | 0.0% |
| 2008 | - ILS | -100.0% |
| 2007 | 44.12 Million ILS | 688.65% |
| 2006 | 5.59 Million ILS | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | 30.31 Million ILS | 353.43% |
| 2023 FY | 30.31 Million ILS | 304.81% |
| 2023 Q2 | 6.68 Million ILS | -82.04% |
| 2023 Q4 | 30.31 Million ILS | 0.0% |
| 2023 Q1 | 37.23 Million ILS | 397.22% |
| 2022 Q4 | 7.48 Million ILS | -5.13% |
| 2022 Q1 | 8.78 Million ILS | -5.05% |
| 2022 FY | 7.48 Million ILS | -19.03% |
| 2022 Q2 | 8.47 Million ILS | -3.48% |
| 2022 Q3 | 7.89 Million ILS | -6.87% |
| 2021 FY | 9.24 Million ILS | 61.84% |
| 2021 Q2 | 10.4 Million ILS | 88.87% |
| 2021 Q3 | 9.85 Million ILS | -5.28% |
| 2021 Q4 | 9.24 Million ILS | -6.17% |
| 2021 Q1 | 5.51 Million ILS | -3.59% |
| 2020 Q4 | 5.71 Million ILS | -16.23% |
| 2020 FY | 5.71 Million ILS | -18.45% |
| 2020 Q1 | 6.9 Million ILS | -1.41% |
| 2020 Q2 | 6.63 Million ILS | -3.98% |
| 2020 Q3 | 6.82 Million ILS | 2.83% |
| 2019 Q3 | 7.17 Million ILS | -3.81% |
| 2019 FY | 7 Million ILS | -85.88% |
| 2019 Q4 | 7 Million ILS | -2.31% |
| 2019 Q1 | 7.8 Million ILS | -84.28% |
| 2019 Q2 | 7.45 Million ILS | -4.38% |
| 2018 FY | 49.62 Million ILS | -30.96% |
| 2018 Q4 | 49.62 Million ILS | -37.96% |
| 2018 Q3 | 79.98 Million ILS | 2.6% |
| 2018 Q2 | 77.95 Million ILS | 7.23% |
| 2018 Q1 | 72.69 Million ILS | 1.15% |
| 2017 Q1 | 74.45 Million ILS | -4.92% |
| 2017 Q4 | 71.87 Million ILS | -6.97% |
| 2017 Q3 | 77.26 Million ILS | 4.38% |
| 2017 FY | 71.87 Million ILS | -8.21% |
| 2017 Q2 | 74.01 Million ILS | -0.59% |
| 2016 Q3 | 86.34 Million ILS | 0.99% |
| 2016 FY | 78.3 Million ILS | -8.09% |
| 2016 Q2 | 85.49 Million ILS | 5.48% |
| 2016 Q4 | 78.3 Million ILS | -9.31% |
| 2016 Q1 | 81.05 Million ILS | -4.87% |
| 2015 Q1 | 89.21 Million ILS | 2.91% |
| 2015 FY | 85.2 Million ILS | -1.72% |
| 2015 Q4 | 85.2 Million ILS | 3.56% |
| 2015 Q3 | 82.27 Million ILS | -0.19% |
| 2015 Q2 | 82.42 Million ILS | -7.61% |
| 2014 Q2 | 77.26 Million ILS | -18.59% |
| 2014 FY | 86.69 Million ILS | -26.59% |
| 2014 Q1 | 94.9 Million ILS | -19.63% |
| 2014 Q4 | 86.69 Million ILS | 6.17% |
| 2014 Q3 | 81.65 Million ILS | 5.69% |
| 2013 Q1 | 25.62 Million ILS | 0.61% |
| 2013 Q2 | 41.86 Million ILS | 63.38% |
| 2013 Q3 | 128.65 Million ILS | 207.31% |
| 2013 FY | 118.09 Million ILS | 363.68% |
| 2013 Q4 | 118.09 Million ILS | -8.21% |
| 2012 Q4 | 25.46 Million ILS | 0.0% |
| 2012 FY | 25.46 Million ILS | 124.15% |
| 2011 FY | 11.36 Million ILS | 20.3% |
| 2010 FY | 9.44 Million ILS | 115.49% |
| 2009 FY | 4.38 Million ILS | 0.0% |
| 2008 FY | - ILS | -100.0% |
| 2007 FY | 44.12 Million ILS | 688.65% |
| 2006 FY | 5.59 Million ILS | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Matricelf Ltd | - ILA | -Infinity% |